High levels of modified ceramides are a defining feature of murine and human cancer cachexia

10.1002/jcsm.12626

Saved in:
Bibliographic Details
Main Authors: Morigny, P., Zuber, J., Haid, M., Kaltenecker, D., Riols, F., Lima, J.D.C., Simoes, E., Otoch, J.P., Schmidt, S.F., Herzig, S., Adamski, J., Seelaender, M., Berriel Diaz, M., Rohm, M.
Other Authors: BIOCHEMISTRY
Format: Article
Published: Wiley Blackwell 2021
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/199004
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-199004
record_format dspace
spelling sg-nus-scholar.10635-1990042024-04-22T03:01:02Z High levels of modified ceramides are a defining feature of murine and human cancer cachexia Morigny, P. Zuber, J. Haid, M. Kaltenecker, D. Riols, F. Lima, J.D.C. Simoes, E. Otoch, J.P. Schmidt, S.F. Herzig, S. Adamski, J. Seelaender, M. Berriel Diaz, M. Rohm, M. BIOCHEMISTRY Cancer cachexia Ceramides Lipidomics Signalling lipids Sphingolipids 10.1002/jcsm.12626 Journal of Cachexia, Sarcopenia and Muscle 11 6 1459-1475 2021-08-24T02:41:59Z 2021-08-24T02:41:59Z 2020 Article Morigny, P., Zuber, J., Haid, M., Kaltenecker, D., Riols, F., Lima, J.D.C., Simoes, E., Otoch, J.P., Schmidt, S.F., Herzig, S., Adamski, J., Seelaender, M., Berriel Diaz, M., Rohm, M. (2020). High levels of modified ceramides are a defining feature of murine and human cancer cachexia. Journal of Cachexia, Sarcopenia and Muscle 11 (6) : 1459-1475. ScholarBank@NUS Repository. https://doi.org/10.1002/jcsm.12626 2190-5991 https://scholarbank.nus.edu.sg/handle/10635/199004 Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ Wiley Blackwell Scopus OA2020
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic Cancer cachexia
Ceramides
Lipidomics
Signalling lipids
Sphingolipids
spellingShingle Cancer cachexia
Ceramides
Lipidomics
Signalling lipids
Sphingolipids
Morigny, P.
Zuber, J.
Haid, M.
Kaltenecker, D.
Riols, F.
Lima, J.D.C.
Simoes, E.
Otoch, J.P.
Schmidt, S.F.
Herzig, S.
Adamski, J.
Seelaender, M.
Berriel Diaz, M.
Rohm, M.
High levels of modified ceramides are a defining feature of murine and human cancer cachexia
description 10.1002/jcsm.12626
author2 BIOCHEMISTRY
author_facet BIOCHEMISTRY
Morigny, P.
Zuber, J.
Haid, M.
Kaltenecker, D.
Riols, F.
Lima, J.D.C.
Simoes, E.
Otoch, J.P.
Schmidt, S.F.
Herzig, S.
Adamski, J.
Seelaender, M.
Berriel Diaz, M.
Rohm, M.
format Article
author Morigny, P.
Zuber, J.
Haid, M.
Kaltenecker, D.
Riols, F.
Lima, J.D.C.
Simoes, E.
Otoch, J.P.
Schmidt, S.F.
Herzig, S.
Adamski, J.
Seelaender, M.
Berriel Diaz, M.
Rohm, M.
author_sort Morigny, P.
title High levels of modified ceramides are a defining feature of murine and human cancer cachexia
title_short High levels of modified ceramides are a defining feature of murine and human cancer cachexia
title_full High levels of modified ceramides are a defining feature of murine and human cancer cachexia
title_fullStr High levels of modified ceramides are a defining feature of murine and human cancer cachexia
title_full_unstemmed High levels of modified ceramides are a defining feature of murine and human cancer cachexia
title_sort high levels of modified ceramides are a defining feature of murine and human cancer cachexia
publisher Wiley Blackwell
publishDate 2021
url https://scholarbank.nus.edu.sg/handle/10635/199004
_version_ 1800914969811746816